China Money Network
Login
Join

Shenzhen Capital Group Joins $43M Round In Frontier Biotechnologies

  • January 4, 2017 — 14:24 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese RMB fund Huaxin Century Investment Group has led a RMB300 million (US$43 million) series C round in Frontier Biotechnologies Inc., a drug development bio-pharmaceutical... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: